IFNA17 and chronic hepatitis B virus infection: A recent study showed that in HBeAg-negative chronic hepatitis B patients, switching from NUCs to PEG-IFNα for 48 weeks significantly reduced virological relapse rates and resulted in higher HBsAg loss rates compared to NUC cessation alone [168].